More men with advanced prostate cancer could be successfully treated with precision drug olaparib 15 Jul 2024 Scientists have discovered a genetic aberration found in some prostate cancers that could allow more men to be successfully treated with targeted drug olaparib Find out more Show/Hide
New tool combining evolution and AI predicts prostate cancer recurrence more than a decade ahead 11 Jul 2024 Combining the principles of evolution with artificial intelligence (AI), scientists have proposed a new way to predict the chance of prostate cancer returning. In a recent study, they harnessed computational methods to capture specific tumour measurements relating to the tumour’s ability to change over time. They then showed that these measurements correlate with disease recurrence more than a decade after the initial diagnosis. Find out more Show/Hide
Thousands of high-risk cancer gene variants identified 04 Jul 2024 Researchers have mapped the exact variants in a gene that dramatically increase a person’s risk of developing several types of cancer. This could lead to improved early detection and targeted treatment across diverse populations. Find out more Show/Hide
Analysis of findings from long-term study reveals more genetic mutations associated with aggressive prostate cancer 02 Jul 2024
Thousands take part in Dave Day tribute to Hairy Biker Dave Myers in support of The Institute of Cancer Research 10 Jun 2024
ASCO 2024: New ultra-sensitive blood test predicts recurrence of breast cancer, months or even years before relapse 01 Jun 2024
ASCO 2024: Prostate cancer spit test better for men with high genetic risk than standard blood test 31 May 2024